Edition:
United States

Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

1.80USD
4:00pm EDT
Change (% chg)

$-0.02 (-1.10%)
Prev Close
$1.82
Open
$1.81
Day's High
$1.82
Day's Low
$1.77
Volume
1,702
Avg. Vol
16,048
52-wk High
$5.49
52-wk Low
$1.70

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.005
Mar '18 0.00 -0.001
FY 2017 Dec '17 0.00 -0.008
Sep '17 0.00 -0.009
Jun '17 0.00 -0.000
Mar '17 0.00 -0.011
FY 2016 Dec '16 0.00 -0.007
Sep '16 0.00 -0.000
Jun '16 0.00 -0.005
Mar '16 0.00 -0.003
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 0.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 119.85 32.14
P/E High - Last 5 Yrs. -- 284.29 46.82
P/E Low - Last 5 Yrs. -- 95.75 24.71
Beta -7.35 0.63 0.87
Price to Sales (TTM) -- 109.82 6.55
Price to Book (MRQ) 3.63 13.72 4.00
Price to Tangible Book (MRQ) 3.64 20.21 6.10
Price to Cash Flow (TTM) -- 69.50 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.68
Dividend Yield - 5 Year Avg -- 0.20 1.45
Dividend 5 Year Growth Rate -- 2.61 -5.91
Payout Ratio(TTM) -- 5.68 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 157.56 7.91
Sales (TTM) vs TTM 1 Yr. Ago -- 91.25 6.56
Sales - 5 Yr. Growth Rate -- 25.47 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago -1,848.15 297.15 26.63
EPS (TTM) vs TTM 1 Yr. Ago -26.74 -- --
EPS - 5 Yr. Growth Rate -- 25.12 7.65
Capital Spending - 5 Yr. Growth Rate -- 39.11 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.22
Current Ratio (MRQ) 2.00 5.52 2.99
LT Debt to Equity (MRQ) 0.00 15.33 11.31
Total Debt to Equity (MRQ) 0.00 18.80 14.15
Interest Coverage (TTM) -- -216.32 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 32.64 54.36
Gross Margin - 5 Yr. Avg. -- 52.76 53.16
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -164.07 16.13
Operating Margin (TTM) -- -618.88 3.36
Operating Margin - 5 Yr. Avg. -- -178.92 11.28
Pre-Tax Margin (TTM) -- -615.68 3.79
Pre-Tax Margin - 5 Yr. Avg. -- -181.48 11.54
Net Profit Margin (TTM) -- -604.79 0.60
Net Profit Margin - 5 Yr. Avg. -- -179.91 7.83
Effective Tax Rate (TTM) -- 11.98 20.73
Effective Tax Rate - 5 Yr. Avg. -- 19.65 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 24,741,437 725,680,242
Net Income/Employee (TTM) -1,873,854 1,102,410 84,001,075
Receivable Turnover (TTM) -- 4.18 5.06
Inventory Turnover (TTM) -- 2.14 3.65
Asset Turnover (TTM) 0.00 0.39 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -129.57 0.35 9.83
Return on Assets - 5 Yr. Avg. -73.50 3.11 10.94
Return on Investment (TTM) -200.66 1.96 12.83
Return on Investment - 5 Yr. Avg. -105.49 2.91 14.05
Return on Equity (TTM) -202.39 1.12 14.95
Return on Equity - 5 Yr. Avg. -106.82 -0.97 15.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -84.29 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Akari Therapeutics PLC

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 7.71%
# of Holders: 12
Total Shares Held: 1,176,491
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.